$247.72 0.36 (0.15%)
19:54 EDT AMGN Stock Quote Delayed 30 Minutes
Previous Close $247.72
Market Cap 163.92B
PE Ratio 78.64
Volume (Avg. Vol.) 6.04M
Day's Range 242.35 - 249.84
52-Week Range 177.05 - 264.97
Dividend & Yield 5.28 (2.13%)
AMGN Stock Predictions, Articles, and Amgen News
- From InvestorPlace
- From the Web
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.
These four strong California stocks deserve your attention and further due diligence to be included in long-term portfolios.
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.
As the world and the markets continue to grapple with the effects of the novel coronavirus outbreak, these innovative healthcare stocks to buy look poised for success.
Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.
Here are three of the best healthcare stocks to buy, as the sector is flashing a 'buy-the-dip' setup to kick off the New Year.
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.
Goldman Sachs analysts came out with three conviction buys on Monday. Here's what else happened in the stock market today.
Folks who haven’t been paying attention to the absolutely huge potential happening in biotech stocks right now -- both in the U.S. and other parts of the world -- have been put on notice.
The biggest risk to Amgen stock comes from health reform that might limit the number of drugs insurers pay for, creating price competition.
Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.
Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.
Trade talks gave a lift to stocks, while Johnson & Johnson will be in focus after the close. Here's what happened in the stock market today.
Netflix, Amgen, Bristol-Myers Squibb, Aurora Cannabis and Foot Locker are our top stock trades for Tuesday. Here's how to trade them.
Celgene news for Thursday about it selling Otezla has CELG stock on the rise as it moves forward with the Bristol-Myers Squibb merger.
Options trading was buzzing on Tuesday, with Amgen, American Airlines and Apple all making notable moves. Here are the metrics that matter moving forward.
Matt McCall is extremely bullish on China and the big opportunities in several sectors, but Chinese biotech stocks top his list.
From Market News Video
Investors in Murphy Oil Corp (MUR) saw new options begin trading today, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MUR options chain for the new November 20th contracts and identified one put and one call contract of particular interest.
From Seeking Alpha
From Seeking Alpha
Murphy Oil (MUR +1.7%) is upgraded to Buy from Neutral with a $14 price target at MKM Partners after shares have depreciated 30% since mid-August, reflecting nearly 40% intrinsic value upside.MKM analyst John Gerdes calculates Murphy should generate $220M in free cash flow in 2020, assuming $610M in net capital spending this year including the Kings Quay monetization; assuming a $625M capex plan next year, the company should generate $110M free cash flow in 2021 and total $810M during 2021-25, which is 50%-55% of the company's market capitalization.For Q3, MKM's production expectation of 171.7K boe/day is in the upper half of the company's 164.5K-174.5K boe/day, Gerdes says.
Navellier RatingsPowered by Portfolio Grader